---
title: PET/CT Radiogenomic Mutation Prediction in Non-Small Cell Lung Cancer Using Multi-Label Learning
url: http://arxiv.org/abs/2608.09721v1
type: paper-summary
date: 2026-08-10
source_paper: 2026-08-10_15-22-37Z_PET_CTRadiogenomicMutationPredictioninNon_SmallCel.md
generated_at: 2026-08-10 22:20
model: nvidia/nemotron-3-nano-4b
---

## Summary
This study proposes a deep‑learning framework that predicts EGFR, TP53 and KRAS mutations in non‑small cell lung cancer using PET/CT imaging data. By applying multi‑label learning, the model’s performance is compared with single‑gene classification, revealing gains for certain gene pairs while others show no benefit.

## Key Takeaways
- Joint pre‑decoding of KRAS and TP53 improves AUC from 0.58 to 0.64 for KRAS and from 0.69 to 0.71 for TP53, demonstrating that combined modeling can enhance detection accuracy.
- For the EGFR/KRAS pair only EGFR benefits from joint learning, indicating that some gene combinations are more synergistic than others.
- The EGFR/TP53 pair shows no improvement with multi‑label learning, suggesting that certain mutation pairs may not be jointly predictive in PET/CT data.

## Context
This work advances AI applications in radiogenomics by integrating multimodal imaging and genetic information to predict oncogenic alterations without tissue biopsy. It highlights how deep learning can overcome the invasiveness of traditional profiling methods, aligning with broader efforts to personalize cancer care through non‑invasive diagnostics.

## Implications
Practitioners can leverage these findings to design mutation‑specific models that maximize diagnostic utility for PET/CT scans in NSCLC patients. The results support targeted development pipelines where multi‑label learning is applied judiciously based on gene pair dynamics, potentially reducing reliance on invasive biopsies and improving patient outcomes.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2608.09721v1)
